Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 16 September 2008, doi:10.1136/bmj.a1673
Cite this as: BMJ 2008;337:a1673
| The first 150 words of the full text of this article appear below. |
The paper by Douglas and Smeeth,1 does not, as is widely claimed, show that both typical and atypical antipsychotics increase the risk of stroke, especially in patients with dementia.
They find that in patients who have had a stroke and who were prescribed antipsychotics by their general practitioners the stroke is more likely to occur during the time antipsychotics are prescribed than before or after. The method used is wide open to biases of different sorts.2
The authors do not consider the possibility that there may be quite direct relations between the clinical situation which leads to the initiation or termination of the prescription of antipsychotics and the stroke. For example, a patient with ongoing deterioration of functioning may have behavioural disturbance and be prescribed an antipsychotic and may then go on to develop what is recognised as a full blown stroke. Likewise, some patients taking antipsychotics will have a
David Curtis, honorary professor of psychiatry1
1 Royal London Hospital, East London (NHS) Foundation Trust, London E1 1BB
david.curtis@qmul.ac.uk
Read all Rapid Responses